METHODS	In the extension , patients in the first three treatment groups continued their regimen ( non-switched group , n = 333 ) while the metformin 500mg bid , linagliptin 5mg qd and placebo groups were re-randomised to one of the three continuing regimens ( switched group , n = 233 ) .\